Francis Pang

Francis Pang is a seasoned professional in market access and pricing, currently serving as Senior Vice President of Global Market Access and International Geographic Expansion at Orchard Therapeutics since 2019. In addition, Francis serves as Chair of the EU Market Access & Value Recognition Advisory Group and as a member of the European Leadership Advisory Group at the Alliance for Regenerative Medicine. Previous roles include membership on the Highly Specialised Technologies Committee and serving as Economic Lead at NICE from 2013 to 2023, and Vice President positions at Amicus Therapeutics and Biogen, focusing on market access in global and regional capacities. Francis also held the role of Senior Director at Shire, specializing in human genetic therapies market access and public affairs. Educational credentials include an M.B.A. from INSEAD, Genomic Medicine studies at the University of Cambridge, and further education at the University of York, EPFL, and Kyoto University.